AU2002362767A1 - Recombinant rabies vaccine and methods of preparation and use - Google Patents

Recombinant rabies vaccine and methods of preparation and use

Info

Publication number
AU2002362767A1
AU2002362767A1 AU2002362767A AU2002362767A AU2002362767A1 AU 2002362767 A1 AU2002362767 A1 AU 2002362767A1 AU 2002362767 A AU2002362767 A AU 2002362767A AU 2002362767 A AU2002362767 A AU 2002362767A AU 2002362767 A1 AU2002362767 A1 AU 2002362767A1
Authority
AU
Australia
Prior art keywords
preparation
methods
rabies vaccine
recombinant rabies
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002362767A
Inventor
Bernard Dietzschold
Craig D. Hooper
Matthias J. Schnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Publication of AU2002362767A1 publication Critical patent/AU2002362767A1/en
Abandoned legal-status Critical Current

Links

AU2002362767A 2001-10-10 2002-10-10 Recombinant rabies vaccine and methods of preparation and use Abandoned AU2002362767A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/328,350 2001-10-10

Publications (1)

Publication Number Publication Date
AU2002362767A1 true AU2002362767A1 (en) 2003-04-22

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003235707A1 (en) Immunogenic preparations and vaccines on the basis of mrna
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2002330943A1 (en) Immunomodulatory compounds and methods of use thereof
AU2001255196A1 (en) Compositions and methods for enhancing immunogenicity of antigens
WO2003059257A8 (en) Anti-angiogenic proteins and fragmentsand methods of use thereof
AU2001241918A1 (en) Methods of enhancing activity of vaccines and vaccine compositions
AU2002326751A1 (en) Immunoglobulin e vaccines and methods of use thereof
AU2002335085A1 (en) Angiopoietins and methods of use thereof
IL157609A0 (en) A vaccine composition and method of using the same
AU2003259374A1 (en) Vaccine comprising il-13 and an adjuvant
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2001292667A1 (en) Immunogenic composition of hepatitis c and methods of use thereof
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2002347464A1 (en) Anti-arthropod vector vaccines methods of selecting and uses thereof
AU2002310237A1 (en) Sponge-derived terpenoids and methods of use
AU2002246926A1 (en) 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
AU2002366544A1 (en) Adjuvant formulations for bacterial and virus vaccines and method of making same
AU2002318104A1 (en) Microparticles and methods for delivery of recombinant viral vaccines
AU2001264824A1 (en) Vaccine and gene therapy vector and methods of use thereof
AU2002362767A1 (en) Recombinant rabies vaccine and methods of preparation and use
AU2002332613A1 (en) Compositions and therapeutic methods for viral infection
AU2002366708A1 (en) Preparation of vaccines using photosensitizer and light
AU2002217820A1 (en) Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection
AUPQ760400A0 (en) Herbical formulations and methods of use thereof